Description
JADBio
Overview
JADBio (Just Add Data Bio) is a leading Automated Machine Learning (AutoML) platform specifically designed for life scientists and healthcare professionals. It enables biomarker discovery, predictive model building, and knowledge extraction from complex data without any coding required.
Founded in 2019 as a spin-off from the University of Crete by Ioannis Tsamardinos (CEO), Vincenzo Lagani, and Pavlos Charonyktakis. Headquarters in Heraklion, Crete, Greece with offices in Los Angeles, California and Denmark.
"Just Add Data" - JADBio's philosophy is to make machine learning accessible to everyone, regardless of data science experience or programming skills.
Key Features
AutoML for Life Sciences
| Feature | Description |
|---|---|
| No-Code ML | Build models without programming |
| Biomarker Discovery | Automated biomarker identification |
| Feature Selection | Intelligent variable selection |
| Multi-Omics Support | Genomics, proteomics, metabolomics |
| Survival Analysis | Time-to-event analysis |
| Small Sample Size | Efficiently handles small datasets |
Supported Data Types
| Type | Application |
|---|---|
| Genomics | Genetic sequencing |
| Transcriptome | Gene expression |
| Proteome | Protein analysis |
| Metabolome | Metabolites |
| Metagenome | Microbiome |
| Clinical Data | Clinical/phenotypic data |
| Medical Images | Medical imaging |
Analysis Types
| Analysis | Description |
|---|---|
| Classification | Binary/multiclass classification |
| Regression | Continuous value prediction |
| Survival Analysis | Time-to-event (death, relapse) |
| Biomarker Discovery | Predictive marker identification |
Use Cases
Biomedical Research
- Biomarker discovery for diagnostics
- Treatment response prediction
- Disease subtype identification
- Cancer survival prognosis
Drug Discovery
- Therapeutic target identification
- Drug repurposing
- Lead compound optimization
- Clinical trial monitoring
Application Areas
| Area | Use |
|---|---|
| Oncology | Cancer biomarkers, prognosis |
| Immunology | Immune response, autoimmunity |
| Chronic Diseases | Diabetes, cardiovascular |
| Infectious Diseases | COVID-19, pathogens |
| Mental Health | Psychiatric biomarkers |
| Aging | Biological age clocks |
Pricing Plans
| Plan | Price | Features |
|---|---|---|
| Basic (Free) | $0 | Full functionality, limited analyses |
| Researcher | Variable | For academic researchers |
| Team 5+ | ~$2,199/mo | API access, survival analysis, up to 10 seats |
| Business Pro 40+ | Custom | AWS container, big data, 1000+ CPUs |
| Classroom | Free | For educators, 30 floating licenses |
Note: All plans include 14-day free trial of the full Team plan.
Technology and Differentiators
What Makes JADBio Unique
| Aspect | Advantage |
|---|---|
| Life Science Specific | Only AutoML designed for biomedical data |
| Small Sample Handling | Works with small datasets (common in biomedicine) |
| High Dimensional Data | Handles millions of features |
| No Overfitting | Unbiased performance estimation |
| Interpretability | Explainable and transparent models |
| Feature Selection | Proprietary selection algorithms |
Algorithms and Methods
- Proprietary feature selection algorithms
- Meta-level learning (ML on ML results)
- Bootstrap validation without hold-out
- Multiple automated ML pipelines
- Hyperparameter optimization
Integrations
| Integration | Description |
|---|---|
| QIAGEN | Global distribution (since 2021) |
| AWS Marketplace | Container deployment |
| REST API | Programmatic integration |
| Indivumed | Strategic partner in oncology |
Founding Team
Ioannis Tsamardinos - CEO & Co-founder
| Data | Detail |
|---|---|
| Title | Professor of Artificial Intelligence |
| University | University of Crete |
| PhD | University of Pittsburgh |
| Publications | 130+ papers, 9,000+ citations |
| Recognition | Top 2% AI researchers worldwide |
| NASA | Algorithm on Deep Space I spacecraft |
| Lab | MensXMachina ("mind from the machine") |
Vincenzo Lagani - Co-founder
| Data | Detail |
|---|---|
| Title | Associate Professor |
| University | Ilia State University, Georgia |
| PhD | University of Calabria, Italy |
| Specialty | Bioinformatics |
Pavlos Charonyktakis - CTO & Co-founder
| Data | Detail |
|---|---|
| Title | Chief Technology Officer |
| Education | MSc Computer Science, University of Crete |
| Role | Technical architecture of JADBio |
History and Timeline
| Date | Milestone |
|---|---|
| 2013 | Gnosis Data Analysis founded (precursor) |
| 2019 | Formal founding of JADBio |
| Jul 2020 | Public platform launch |
| Nov 2020 | Partnership with Indivumed for oncology |
| Mar 2021 | Distribution agreement with QIAGEN |
| Sep 2021 | "Spin-off of the Year 2021" Award (Elevate Greece) |
| 2022 | ERC Proof of Concept Grant (€150K) |
| 2022 | Selected by EIC for BIO2022 San Diego |
| 2023 | Partnership with BioLizard |
| 2023 | Partnership with DiamiR Biosciences |
Awards and Recognition
| Award | Year | Granted By |
|---|---|---|
| Spin-off of the Year | 2021 | Elevate Greece (1st place out of 250 companies) |
| ERC Proof of Concept Grant | 2022 | European Research Council (€150K) |
| EIC Selection | 2022 | European Innovation Council (BIO2022) |
Partnerships and Clients
Strategic Partners
| Partner | Type | Description |
|---|---|---|
| QIAGEN | Distribution | Global distribution since 2021 |
| Indivumed | Investor/Client | Oncology multi-omics platform |
| BioLizard | Partner | ML capabilities integration |
| DiamiR Biosciences | Partner | Assay development |
Notable Clients
- TCGA (The Cancer Genome Atlas)
- Global research institutions
- Pharmaceutical companies
- NHS (National Health Service, UK)
Company Information
| Data | Value |
|---|---|
| Legal Name | JADBio - Gnosis DA S.A. |
| Founded | 2019 |
| Headquarters | Heraklion, Crete, Greece |
| Address | N. Plastira 100, Vassilika Vouton, 70013 |
| Other Offices | Los Angeles (CA), Denmark |
| Employees | ~11-23 |
| Status | Active, growing |
| Funding | Public grants + private investment |
Competitors
| Competitor | Difference vs JADBio |
|---|---|
| DataRobot | General-purpose, not life science specific |
| H2O.ai | Open-source, requires more technical expertise |
| Google AutoML | General-purpose, not optimized for small samples |
| Azure AutoML | General enterprise, not biomedical-specific |
| KNIME | Low-code but less automated |
JADBio's competitive advantage: The only AutoML specifically designed for life science data, capable of handling small datasets with high dimensionality (common situation in biomedical research).
Publications and Scientific Validation
JADBio has been validated in 40+ scientific publications in areas including:
- Oncology and cancer diagnostics
- COVID-19 and infectious diseases
- Aging biomarkers
- Suicide risk prediction
- Autism screening
- Bipolar disorders
PROS ✅
- No-Code - Accessible without programming
- Life Science Specific - Designed for biomedical data
- Small Samples - Works with limited data
- High Dimensional - Handles millions of features
- No Overfitting - Reliable performance estimation
- Interpretable - Explainable models
- Feature Selection - Advanced proprietary algorithms
- Multi-Omics - Integrates multiple data types
- API Available - Programmatic integration
- Free Tier - Basic plan free
- Validated - 40+ scientific publications
- QIAGEN Partnership - Global distribution
CONS ❌
- Life Science Focus - Less versatile for other domains
- Learning Curve - ML concepts may be new
- Pricing - Team plans costly for startups
- No Deep Learning - Focused on classical ML
- Limited Customization - Less flexible than coding
- Small Company - Fewer resources than big tech
Key Features
No-code AutoML without programming
Automated biomarker discovery
Multi-omics genomics proteomics metabolomics
Survival analysis time-to-event
Proprietary feature selection algorithms
Small sample size dataset handling
High dimensional millions of features
Classification binary multiclass
Regression continuous prediction
Interpretable explainable models
REST API programmatic integration
AWS Marketplace container deployment
QIAGEN partnership global distribution
Medical images analysis
Clinical phenotypic data
Bootstrap validation without hold-out
Automatic hyperparameter optimization
Model visualization graphs reports
Team collaboration project sharing
Free tier basic plan available
Use Cases
Biomarker discovery diagnostics
Cancer prognosis survival oncology
Drug discovery therapeutic targets
Treatment response prediction
Disease subtype identification
Clinical trial monitoring
Drug repurposing repositioning
Lead compound optimization
COVID-19 infectious diseases
Mental health psychiatric biomarkers
Aging biological age clocks
Immunology immune response
Chronic diseases diabetes cardiovascular
Autism screening detection
Suicide risk assessment
Microbiome metagenomics analysis
Gene expression transcriptomics
Protein analysis proteomics
Metabolomics metabolites discovery
Precision medicine personalized healthcare
Tags
Information
Company
JADBio - Gnosis DA S.A.
Website
jadbio.com